NCT01535157 2020-08-27Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian CancerSouth Plains Oncology ConsortiumPhase 1/2 Terminated12 enrolled
NCT00288067 2014-10-06Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1/2 Terminated32 enrolled 7 charts